Many Cancer Drugs Don’t Extend Life

Many Cancer Drugs Don’t Extend Life

0 Anmeldelser
0
Episode
855 of 890
Længde
26M
Sprog
Engelsk
Format
Kategori
Fakta

Treating cancer is a massive business. In 2024 alone, cancer treatments generated at least $200 billion in worldwide sales for the pharmaceutical industry, more than the obesity drug rush. But a Bloomberg News analysis showed that fewer than half of treatments reviewed — some of which have painful side effects — have been shown to extend patients’ lives. On today’s Big Take podcast, Bloomberg senior healthcare reporter Robert Langreth takes host David Gura inside what some doctors call the “cancer-industrial complex” — from the regulatory landscape that ushered in a wave of lucrative new drugs to the damaging financial and health impacts some treatments can have on patients. Read more: Cancer Drugs Cost More Than Ever. They Often Don’t Extend Lives. The Implants Were Supposed to Dissolve. They Didn’t. Pharma Is Pushing $200,000 Cancer Drugs When Cheaper Doses May Work Cancer Doctors Are Making a Fortune Off Drug-Trial Participants One Generic Cancer Drug Costs $35. Or $134. Or $13,000.

See omnystudio.com/listener for privacy information.


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Many Cancer Drugs Don’t Extend Life

Other podcasts you might like ...